Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Category Archives: Organization/Business News
Therasense In Action – Warren Woessner To Speak At AIPLA
On Saturday, October 27th, I will one of the speakers in the Closing Plenary Session of the Annual AIPLA Meeting in Washington, DC. Since I was assigned to do part of the “Ethics” track, I will be speaking on post-Therasense … Continue reading
Posted in Organization/Business News, People
Tagged AIPLA, intellectual property, ip, IP law tools, Patent Law, patent strategy, patents, Warren Woessner
Leave a comment
Savior or Candidate for “Worst Patentee”? Nutriset
Last Sunday’s New York Times magazine had a provocative article about Plumpy’nut, a nutritive peanut paste that is foil-packaged so it does not need refrigeration. When eaten by malnourished children it can “cure” them in a relatively brief period of time. It … Continue reading
Posted in Organization/Business News
Tagged intellectual property, ip, New York Times, Nutriset, Patent Law, plumpy nut, Warren Woessner
Leave a comment
Is The “Golden Rule” Of Biological Drugs At Hand?
I just finished speaking on IP issues involving biomarkers at a Q1 Conference in the Bay Area. Before the conference started, I spoke to the head patent counsel of a well-known bio/pharma company. He said, to my initial shock, that … Continue reading
UNIVERSITY OF PITTSBURGH v. HEDRICK – ON A (CLEAR) CONCEPTION DAY
From a prosecutor’s standpoint, the ‘231 patent (link at bottom of this post) has “dream claims” to a new class of stem cells. Claim 1 reads: An isolated adipose-derived stem cell that can differentiate into two or more of the … Continue reading